Past Events
Taiwan-US: Pioneering Innovation in Smart Manufacturing
2024 US-Taiwan Defense Industry Conference
The Semiconductor Industry’s New Role in Global Affairs
Reception Celebrating SelectUSA and AmCham Taiwan Doorknock 2024
USTBC Energy Lunch with AIT Chair Laura Rosenberger
Media Mention: Council President talks semiconductor supply chain on NTD Business
US-Taiwan Business Council President Rupert Hammond-Chambers appeared on NTD Business News on April 2, 2021. He talked about the global semiconductor supply chain and its vulnerability to disruptions. President Hammond-Chambers said “What if the Chinese were to block Taiwan and sever Taiwan’s ability to export its products, including semiconductors? We’d be seeing significant disruptions.” It […]
Statement of Condolences and Support for Taiwan
Statement of condolences and support for Taiwan on the terrible train accident on April 2, 2021. USTBC remains a committed partner to the people of Taiwan, and we extend to them our warmest thoughts and sincere wishes for peace and solace during this difficult time.
Council Partners with TECO Chicago on “Taiwan-U.S. Business Forum in the Midwest”
March 23-24, 2021, the US-Taiwan Business Council partnered with TECO Chicago on the “Taiwan-U.S. Business Forum in the Midwest” webinar
Editorial: A Chip Problem of Detroit’s Own Making
In The Wall Street Journal, USTBC President Rupert Hammond-Chambers argues that the American automobile industry chip shortage is primarily of its own making. U.S. reliance on Taiwan’s chip production further underscores the necessity of binding Taiwan’s technology and security closer to the United States.
Statement: Taiwan Is an Important U.S. Partner in the Chip Supply Chain
USTBC Statement: Chip supply chain issues in the U.S. auto industry are of significant concern, but it is not due to punitive action by a Taiwan company.
Report: Taiwan Healthcare Policies and U.S.-Taiwan Relations
A US-Taiwan Business Council strategic report on the healthcare industry in Taiwan. The report examines outstanding regulatory and other matters in the pharmaceutical and medical device industries, and looks at potential future opportunities for U.S.-Taiwan bilateral cooperation within the healthcare sector.